Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
Maddison Rose, Joshua T. Burgess, Kenneth J. O’Byrne, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 511

Showing 1-25 of 511 citing articles:

DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy
Ruixue Huang, Ping‐Kun Zhou
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 499
Molecular targeted therapy for anticancer treatment
Hye‐Young Min, Ho‐Young Lee
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 10, pp. 1670-1694
Open Access | Times Cited: 247
Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer
Marilyne Labrie, Joan S. Brugge, Gordon B. Mills, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 323-339
Open Access | Times Cited: 219
The expanding universe of PARP1-mediated molecular and therapeutic mechanisms
Dan Huang, W. Lee Kraus
Molecular Cell (2022) Vol. 82, Iss. 12, pp. 2315-2334
Open Access | Times Cited: 158
The multiple mechanisms of MCL1 in the regulation of cell fate
Hayley Widden, William J. Placzek
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 103
New and Emerging Targeted Therapies for Advanced Breast Cancer
Kristie Lau, Alexandra M. Tan, Yihui Shi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2288-2288
Open Access | Times Cited: 102
Advances in PET imaging of cancer
Johannes Schwenck, Dominik Sonanini, Jonathan Cotton, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 7, pp. 474-490
Closed Access | Times Cited: 102
Recent advances in DDR (DNA damage response) inhibitors for cancer therapy
Binbin Cheng, Wei Pan, Yi Xing, et al.
European Journal of Medicinal Chemistry (2022) Vol. 230, pp. 114109-114109
Closed Access | Times Cited: 84
Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
Yifat Geffen, Shankara Anand, Yo Akiyama, et al.
Cell (2023) Vol. 186, Iss. 18, pp. 3945-3967.e26
Open Access | Times Cited: 70
A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
Hitesh Kumar, Neha Gupta, Rupshee Jain, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 271-292
Open Access | Times Cited: 57
PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy
Jeremy M. Kelm, Deepti S. Pandey, Evan Malin, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 50
Causes and consequences of DNA single-strand breaks
Keith W. Caldecott
Trends in Biochemical Sciences (2023) Vol. 49, Iss. 1, pp. 68-78
Open Access | Times Cited: 43
Implementing Whole Genome Sequencing (WGS) in Clinical Practice: Advantages, Challenges, and Future Perspectives
Petar Brlek, Luka Bulić, Matea Bračić, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 504-504
Open Access | Times Cited: 33
New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives
Viola Previtali, Greta Bagnolini, Andrea Ciamarone, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11488-11521
Open Access | Times Cited: 16
ADP-ribosylation of DNA and RNA
Joséphine Groslambert, Evgeniia Prokhorova, Ivan Ahel
DNA repair (2021) Vol. 105, pp. 103144-103144
Open Access | Times Cited: 79
Exploiting replication gaps for cancer therapy
Ke Cong, Sharon B. Cantor
Molecular Cell (2022) Vol. 82, Iss. 13, pp. 2363-2369
Open Access | Times Cited: 67
Pan-cancer Analysis of Homologous Recombination Repair–associated Gene Alterations and Genome-wide Loss-of-Heterozygosity Score
C. Benedikt Westphalen, Alexander D. Fine, Fabrice André, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 7, pp. 1412-1421
Open Access | Times Cited: 64
PARP1: Structural insights and pharmacological targets for inhibition
Jacob O. Spiegel, Bennett Van Houten, Jacob D. Durrant
DNA repair (2021) Vol. 103, pp. 103125-103125
Open Access | Times Cited: 63
Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors
Negesse Mekonnen, Hobin Yang, Young Kee Shin
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 57
MARTs and MARylation in the Cytosol: Biological Functions, Mechanisms of Action, and Therapeutic Potential
Sridevi Challa, MiKayla S Stokes, W. Lee Kraus
Cells (2021) Vol. 10, Iss. 2, pp. 313-313
Open Access | Times Cited: 56
The Hippo Signaling Pathway in Cancer: A Cell Cycle Perspective
Yi Xiao, Jixin Dong
Cancers (2021) Vol. 13, Iss. 24, pp. 6214-6214
Open Access | Times Cited: 56
Apoptosis induction, PARP-1 inhibition, and cell cycle analysis of leukemia cancer cells treated with novel synthetic 1,2,3-triazole-chalcone conjugates
Esraa M. Othman, Eman A. Fayed, Ebtehal M. Husseiny, et al.
Bioorganic Chemistry (2022) Vol. 123, pp. 105762-105762
Closed Access | Times Cited: 55
Immediate-Early, Early, and Late Responses to DNA Double Stranded Breaks
Shaylee R. Kieffer, Noel F. Lowndes
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 49
CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devil
Fatemeh Nasiri, Mehrasa Kazemi, Seyed Mohamad Javad Mirarefin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 49
Iron Administration Overcomes Resistance to Erastin-Mediated Ferroptosis in Ovarian Cancer Cells
Anna Martina Battaglia, Alessandro Sacco, Ida Perrotta, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top